pandem
caus
sever
acut
respiratori
coronaviru
becom
seriou
challeng
health
system
worldwid
despit
favor
clinic
cours
case
mortal
rate
expect
patient
treat
intens
care
unit
icu
report
shown
increas
risk
death
older
patient
exist
comorbid
potenti
biomark
associ
sever
patient
complex
limit
evid
pathogenesi
manag
critic
ill
patient
challeng
multipl
recent
studi
provid
valuabl
clinic
laboratori
featur
hospit
patient
mani
inform
complet
potenti
overlap
data
therefor
find
comprehens
systemat
review
help
physician
understand
diseas
make
decis
critic
ill
patient
studi
perform
quantit
evid
synthesi
clinic
laboratori
factor
associ
mortal
patient
search
peerreview
pubm
web
scienc
scopu
embas
gray
googl
scholar
biorxiv
medrxiv
literatur
identifi
studi
compar
clinic
data
laboratori
paramet
hematolog
biochem
inflammatori
marker
coagul
factor
blood
ga
analysi
complic
nonsurvivor
survivor
includ
studi
provid
clinic
data
least
one
laboratori
paramet
previous
mention
exclud
public
potenti
overlap
report
studi
data
extract
possibl
case
potenti
overlap
data
select
studi
complet
inform
report
screen
two
stage
screen
titl
abstract
follow
retriev
screen
fulltext
articl
search
perform
januari
april
without
languag
restrict
refer
list
elig
studi
review
also
evalu
identifi
addit
studi
inclus
follow
search
term
use
sever
acut
respiratori
syndrom
coronaviru
coronaviru
coronavirus
data
public
extract
two
author
crosscheck
accuraci
outcom
interest
inhospit
death
clinic
data
laboratori
paramet
complic
consid
predictor
variabl
effect
size
report
mean
differ
md
standard
mean
differ
smd
continu
variabl
risk
ratio
rr
dichotom
variabl
confid
interv
ci
studi
report
data
predictor
variabl
pool
analysi
estim
data
avail
variabl
randomeffect
model
use
pool
result
p
use
determin
signific
cohen
classif
use
interpret
magnitud
effect
size
laboratori
find
smd
consid
larg
effect
http
doi
size
statist
heterogen
quantifi
index
analys
conduct
use
review
manag
cochran
im
copenhagen
denmark
screen
titl
abstract
fulltext
articl
assess
elig
studi
exclud
due
potenti
overlap
data
four
retrospect
chines
studi
includ
data
collect
patient
admit
tongji
hospit
renmin
hospit
number
hospit
jinyintan
hospit
wuhan
pulmonari
hospit
studi
provid
data
patient
male
femal
confirm
infect
rtpcr
survivor
nonsurvivor
found
increas
risk
inhospit
death
older
patient
tabl
show
detail
result
metaanalysi
compar
clinic
laboratori
data
nonsurvivor
survivor
result
metaanalysi
may
provid
insight
pathogenesi
progress
reinforc
evid
ageassoci
immun
alter
sustain
comorbid
associ
poor
prognosi
patient
addit
find
highlight
earli
marker
risk
death
patient
shown
use
angiotensinconvert
enzym
receptor
invad
host
cell
especi
kidney
lung
heart
lead
enhanc
releas
cytokin
hyperinflammatori
state
implic
multiorgan
damag
patient
metaanalysi
show
import
differ
biochem
marker
organ
injuri
infectionrel
indic
survivor
nonsurvivor
therefor
infect
may
worsen
preexist
chronic
inflammatori
condit
hypertens
diabet
cardiovascular
diseas
older
patient
lead
death
lung
inflammatori
respons
due
infect
increas
alveolarcapillari
permeabl
result
alveolar
edema
decreas
ga
exchang
hypoxemia
progress
dyspnea
impair
ga
exchang
found
sever
critic
ill
patient
commonli
associ
ard
devast
condit
requir
complex
icu
manag
focus
lung
protect
ventil
avoid
fluid
overload
support
organ
function
interestingli
metaanalysi
show
earli
respiratori
limit
prognost
marker
sever
diseas
although
dyspnea
describ
predomin
complaint
patient
earli
recognit
respiratori
distress
make
differ
relat
prognosi
patient
dysregul
immun
respons
sever
critic
ill
patient
seem
associ
cytokin
storm
increas
amount
cytokin
especi
associ
lymphopenia
decreas
cell
count
sever
lung
injuri
patient
found
inflammatori
cytokin
may
lead
apoptosisinduc
lymphopenia
function
exhaust
cytotox
lymphocyt
lead
diseas
progress
receptor
antagonist
investig
control
immun
respons
inflamm
sever
diseas
moreov
found
larg
effect
size
procalcitonin
nonsurvivor
patient
may
associ
releas
cytokin
especi
well
known
procalcitonin
better
marker
estim
sever
prognosi
cours
sepsi
help
guid
antibiot
manag
therefor
increas
level
procalcitonin
critic
ill
patient
repres
bacteri
coinfect
collect
blood
cultur
bacteria
need
prompt
respons
studi
wang
et
al
patient
die
associ
bacteri
infect
found
sepsi
associ
increas
risk
death
covid
releas
proinflammatori
cytokin
endotheli
dysfunct
increas
oxid
stress
may
also
lead
hypercoagul
state
patient
infect
addit
sepsi
commonli
associ
arteri
venou
thrombosi
along
microvascular
embol
found
prolong
pt
increas
ddimer
thrombocytopenia
nonsurvivor
patient
suggest
dic
also
presenc
dic
significantli
associ
increas
risk
death
critic
ill
patient
recommend
earli
initi
ivig
low
molecular
weight
heparin
lmwh
therapi
allevi
hypercoagul
state
improv
prognosi
critic
type
patient
although
differ
scenario
consid
interpret
death
includ
environment
factor
therapeut
limit
result
present
studi
import
implic
make
earli
clinic
laboratori
indic
avail
relat
increas
risk
death
understand
physician
make
decis
practic
critic
care
patient
infect
unfortun
high
number
studi
potenti
overlap
data
compromis
strength
avail
evid
result
metaanalysi
base
standard
univari
model
studi
without
overlap
report
publish
allow
allow
account
confound
factor
summari
metaanalysi
show
older
age
presenc
chronic
inflammatori
state
dyspnea
diseas
onset
decreas
ga
exchang
increas
level
lymphopenia
decreas
count
cell
chang
biochem
indic
coagul
abnorm
includ
prolong
pt
increas
ddimer
thrombocytopenia
import
predictor
mortal
patient
moreov
increas
risk
death
patient
develop
ard
cardiac
injuri
acut
kidney
diseas
dic
sepsi
paulo
martinsfilho
carolina
santo
souza
tavar
victor
santo
contribut
equal
manuscript
studi
receiv
financi
sourc
author
declar
conflict
interest
